West Nile Virus Encephalitis in A Patient with Chronic Lymphocytic Leukemia
Main Article Content
Keywords
chronic lymphocytic leukemia, West Nile virus, immunodeficiency
Abstract
N/A
Downloads
Download data is not yet available.
Abstract 31
PDF Downloads 28
HTML Downloads 1
References
1) Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804-815. doi: 10.1056/NEJMra041720
2) Morrison VA. Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches. Best Pract Res Clin Haematol 2010; 23: 145-153. doi: 10.1016/j.beha.2009.12.004.
3) Fattizzo B, Barcellini W. Autoimmune cytopenias in chronic lymphocytic leukemia: focus on molecular aspects. Front Oncol. 2020 Jan 10;9:1435. doi: 10.3389/fonc.2019.01435. eCollection 2019.
4) Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013 Jul 17;310(3):308-15. doi: 10.1001/jama.2013.8042.
5) Zeller H, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):147-56. doi: 10.1007/s10096-003-1085-1. Epub 2004 Feb 19.
6) O'Leary DR, Kuhn S, Kniss KL, Hinckley AF, Rasmussen SA, Pape WJ, Kightlinger LK, Beecham BD, Miller TK, Neitzel DF, Michaels SR, Campbell GL, Lanciotti RS, Hayes EB. Birth outcomes following West Nile virus infection of pregnant women in the United States; 2003-2004. Pediatrics. 2006 Mar;117(3):e537-45. doi: 10.1542/peds.2005-2024.
7) Popescu CP, Florescu SA, Hasbun R, Harxhi A, Evendar R, Kahraman H, Neuberger A, Codreanu D, Zaharia MF, Tosun S, Ceausu E, Ruta SM, Dragovac G, Pshenichnaya N, Gopatsa G, Shmaylenko O, Nagy É, Malbasa JD, Strbac M, Pandak N, Pullukcu H, Lakatos B, Cag Y, Cascio A, Coledan I, Oncu S, Erdem H. Prediction of unfavourable outcomes in West Nile virus neuroinvasive infection – results of a multinational ID-IRI study. J Clin Virol. 2020 Jan;122:104213. doi: 10.1016/j.jcv.2019.104213. Epub 2019 Nov 11
8) Forconi F, Moss P. Perturbation of the normal immune system in patients with CLL. lood. 2015 Jul 30;126(5):573-81. doi: 10.1182/blood-2015-03-567388. Epub 2015 Jun 17.
9) D’Arena G, Rossi G, Vannata B, Deaglio S, Mansueto G, D’Auria F, Statuto T, Simeon V, De Martino L, Marandino A, Del Poeta G, De Feo V, Musto P. Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases. Mediterr J Hematol Infect Dis 2012; 4; e2012053 2012;4(1):e2012053. doi: 10.4084/MJHID.2012.053. Epub 2012 Aug 9.
10) D’Arena G, Guariglia R, La Rocca F. Tirino S, Condelli V, De Martino L, De Feo V, Musto P. Autoimmune cytopenias in chronic lymphocytic leukemia. Clin Dev Immunol. 2013;2013:730131. doi: 10.1155/2013/730131. Epub 2013 Apr 16.
11) Arruga F, Baffour Gyau B, Iannello A, Vitale N, Vaisitti T, Deaglio S. Immune response dysfunction in chronic lymphocytic leukemia: dissecting molecular mechanisms and microenvironmental conditions. Int J Mol Sci. 2020 Mar 6;21(5):1825. doi: 10.3390/ijms21051825.
12) Purroy N, Tong YE, Lemvigh CK, Cieri N, S Li, Parry EM, Zhang W, Rassenti LZ, Kipps TJ, Slager SL, Kay NE, Lesnick C, Shanafelt TD, Ghia P, Scarfò L, Livak K, Kharchenko PV, Neuberg DS, Olsen LR, Jan J, Gohil SH, Wu CJ. Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib. Blood 2022; 139: 2252-2256. doi: 10.1182/blood.2021013926.
13) Danilov AV. Immunity in CLL: corrupt at inception? Blood 2022; 139: 2104-2105. doi: 10.1182/blood.2022015413.
1) Hollander H, Schaefer PW, Hedley-Whyte T. Case 22-2005: An 81-year-old man with cough, fever, and altered mental status. N Engl J Med 2005; 353: 287-95. doi: 10.1056/NEJMcpc059017
2) Ferrarini I, Rigo A, Gandini A, Vinante F. West Nile encephalitis in haematological setting: report of two cases and a brief review of literature. Mediterr J Hematol Infect Dis 2019; 11; e2019033 10.4084/MJHID.2019.033
2) Morrison VA. Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches. Best Pract Res Clin Haematol 2010; 23: 145-153. doi: 10.1016/j.beha.2009.12.004.
3) Fattizzo B, Barcellini W. Autoimmune cytopenias in chronic lymphocytic leukemia: focus on molecular aspects. Front Oncol. 2020 Jan 10;9:1435. doi: 10.3389/fonc.2019.01435. eCollection 2019.
4) Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013 Jul 17;310(3):308-15. doi: 10.1001/jama.2013.8042.
5) Zeller H, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):147-56. doi: 10.1007/s10096-003-1085-1. Epub 2004 Feb 19.
6) O'Leary DR, Kuhn S, Kniss KL, Hinckley AF, Rasmussen SA, Pape WJ, Kightlinger LK, Beecham BD, Miller TK, Neitzel DF, Michaels SR, Campbell GL, Lanciotti RS, Hayes EB. Birth outcomes following West Nile virus infection of pregnant women in the United States; 2003-2004. Pediatrics. 2006 Mar;117(3):e537-45. doi: 10.1542/peds.2005-2024.
7) Popescu CP, Florescu SA, Hasbun R, Harxhi A, Evendar R, Kahraman H, Neuberger A, Codreanu D, Zaharia MF, Tosun S, Ceausu E, Ruta SM, Dragovac G, Pshenichnaya N, Gopatsa G, Shmaylenko O, Nagy É, Malbasa JD, Strbac M, Pandak N, Pullukcu H, Lakatos B, Cag Y, Cascio A, Coledan I, Oncu S, Erdem H. Prediction of unfavourable outcomes in West Nile virus neuroinvasive infection – results of a multinational ID-IRI study. J Clin Virol. 2020 Jan;122:104213. doi: 10.1016/j.jcv.2019.104213. Epub 2019 Nov 11
8) Forconi F, Moss P. Perturbation of the normal immune system in patients with CLL. lood. 2015 Jul 30;126(5):573-81. doi: 10.1182/blood-2015-03-567388. Epub 2015 Jun 17.
9) D’Arena G, Rossi G, Vannata B, Deaglio S, Mansueto G, D’Auria F, Statuto T, Simeon V, De Martino L, Marandino A, Del Poeta G, De Feo V, Musto P. Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases. Mediterr J Hematol Infect Dis 2012; 4; e2012053 2012;4(1):e2012053. doi: 10.4084/MJHID.2012.053. Epub 2012 Aug 9.
10) D’Arena G, Guariglia R, La Rocca F. Tirino S, Condelli V, De Martino L, De Feo V, Musto P. Autoimmune cytopenias in chronic lymphocytic leukemia. Clin Dev Immunol. 2013;2013:730131. doi: 10.1155/2013/730131. Epub 2013 Apr 16.
11) Arruga F, Baffour Gyau B, Iannello A, Vitale N, Vaisitti T, Deaglio S. Immune response dysfunction in chronic lymphocytic leukemia: dissecting molecular mechanisms and microenvironmental conditions. Int J Mol Sci. 2020 Mar 6;21(5):1825. doi: 10.3390/ijms21051825.
12) Purroy N, Tong YE, Lemvigh CK, Cieri N, S Li, Parry EM, Zhang W, Rassenti LZ, Kipps TJ, Slager SL, Kay NE, Lesnick C, Shanafelt TD, Ghia P, Scarfò L, Livak K, Kharchenko PV, Neuberg DS, Olsen LR, Jan J, Gohil SH, Wu CJ. Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib. Blood 2022; 139: 2252-2256. doi: 10.1182/blood.2021013926.
13) Danilov AV. Immunity in CLL: corrupt at inception? Blood 2022; 139: 2104-2105. doi: 10.1182/blood.2022015413.
1) Hollander H, Schaefer PW, Hedley-Whyte T. Case 22-2005: An 81-year-old man with cough, fever, and altered mental status. N Engl J Med 2005; 353: 287-95. doi: 10.1056/NEJMcpc059017
2) Ferrarini I, Rigo A, Gandini A, Vinante F. West Nile encephalitis in haematological setting: report of two cases and a brief review of literature. Mediterr J Hematol Infect Dis 2019; 11; e2019033 10.4084/MJHID.2019.033